51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
26 °P sammeln
  • Broschiertes Buch

Drug targeting has the potential to reduce side effects and to increase pharmacological response. The colon can be liable to numerous pathological conditions, such as constipation, Crohn's disease, ulcerative colitis, carcinomas and infections. Ulcerative colitis (UC) is a chronic inflammation of the large intestine. It would be ideal to treat UC with topical corticosteroids that are poorly bioavailable to minimize systemic side effects.

Produktbeschreibung
Drug targeting has the potential to reduce side effects and to increase pharmacological response. The colon can be liable to numerous pathological conditions, such as constipation, Crohn's disease, ulcerative colitis, carcinomas and infections. Ulcerative colitis (UC) is a chronic inflammation of the large intestine. It would be ideal to treat UC with topical corticosteroids that are poorly bioavailable to minimize systemic side effects.
Autorenporträt
Ibrahim Elsayed is a postdoctoral research associate at the Faculty of Computer Science, University of Vienna. He received his MSc in 2005 from the University of Vienna and his PhD with distinction in 2011 from the Vienna University of Technology, both in Business Informatics.¿¿ ¿